Skip to content

A comparison of quality of recovery after erector spinae block given with 20ml vs 30 ml of 0.375% Ropivacaine in patients undergoing modified radical mastectomy.

A randomized double blind study comparing quality of recovery after erector spinae block given with 20ml vs 30ml of 0.375% Ropivacaine in patients undergoing modified radical mastectomy.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055300
Enrollment
98
Registered
2023-07-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: ERECTOR SPINAE PLANE BLOCK: In this arm general anesthesia will be induced and after giving erector spinae plane block 20ml of 0.375% Ropivacaine will be administered. Control Intervent

Sponsors

Tata Main Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade 1 to 3. Patients undergoing single side modified radical mastectomy for breast cancer.

Exclusion criteria

Exclusion criteria: Patients refusing to participate in study. Bilateral breast surgery. Patients with allergy to local anesthetics. Patients with coagulopathy , infection at site of block and patients with neurological deficits. Patients on anti depressants or psychiatric drugs. Patients previously on pain medication.

Design outcomes

Primary

MeasureTime frame
Mean QoR (Quality of Recovery) 40 ScoreTimepoint: 24 HOURS

Secondary

MeasureTime frame
Mean 24 hours VAS score. Mean opioid consumption in first 24 hours post operatively. Duration of block (Time of administration of block to first dose of rescue analgesic).Timepoint: 0, 30, 60, 90 minutes and then 2, 4, 6, 12, 16, 20 and 24 hours.

Countries

India

Contacts

Public ContactDr Srividhya

Tata Main Hospital , Jamshedpur

drsrividhya@tatasteel.com7763807752

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026